Finalized SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 in support of accelerated approval pathway; topline data expected in ...
A black-bellied whistling duck named Earl Grey presented at ZooTampa with sudden weakness in his right leg. X-rays were taken ...
Earnings call Novo Nordisk delivered Q2 2026 adjusted sales growth of 7% YoY (CER) to DKK 78.5 billion, led by strong obesity franchise expansion and robust GLP-1 volume growth, despite lower realized ...